JPS59169497A - Production of l-lysine - Google Patents

Production of l-lysine

Info

Publication number
JPS59169497A
JPS59169497A JP58043742A JP4374283A JPS59169497A JP S59169497 A JPS59169497 A JP S59169497A JP 58043742 A JP58043742 A JP 58043742A JP 4374283 A JP4374283 A JP 4374283A JP S59169497 A JPS59169497 A JP S59169497A
Authority
JP
Japan
Prior art keywords
lysine
strain
producing
cultured
medium
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP58043742A
Other languages
Japanese (ja)
Other versions
JPH0458316B2 (en
Inventor
Toshihide Nakanishi
中西 俊秀
Tomoki Azuma
東 朋樹
Toshihiko Hirao
平尾 俊彦
Kiyoji Hattori
服部 喜代次
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
KH Neochem Co Ltd
Original Assignee
Kyowa Hakko Kogyo Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kyowa Hakko Kogyo Co Ltd filed Critical Kyowa Hakko Kogyo Co Ltd
Priority to JP58043742A priority Critical patent/JPS59169497A/en
Publication of JPS59169497A publication Critical patent/JPS59169497A/en
Publication of JPH0458316B2 publication Critical patent/JPH0458316B2/ja
Granted legal-status Critical Current

Links

Abstract

PURPOSE:A strain in Corynebacterium, which is capable of producing L-lysine and resistant to the antibiotics produced by Bacillus, is cultured to effect low- cost production of L-lysine which is used as a medicine or food additive, on a practical scale. CONSTITUTION:A strain in Corynebacterium or Brevibacterium, which is resistant to antibiotics produced by Bacillus such as thermolysin or subtilisin, and capable of producing L-lysine, such as Corynebacterium glutamicum H-3330 (FERM P-6819) is cultured in an enriched medium to produce L-lysine, which is collected from the culture mixture.

Description

【発明の詳細な説明】 本発明は発酵法によるL−リジンの製造法に関し、さら
に詳しくは、コリネバクテリウム属またはブレビバクテ
リウム属に属し、L−リジン生産能を有し、かつ、バチ
ルス属細菌の生産する抗菌性物質に対し抵抗性を有する
菌株を栄養培地に培養し、培養物中にこれを生成せしめ
生成蓄積したL−リジンを該培養物から採取することを
特徴とする発−法によるし一リジンの製造法に関する。
DETAILED DESCRIPTION OF THE INVENTION The present invention relates to a method for producing L-lysine by a fermentation method, and more particularly, the present invention relates to a method for producing L-lysine by a fermentation method, and more specifically, a method for producing L-lysine that belongs to the genus Corynebacterium or Brevibacterium and has the ability to produce L-lysine, and that belongs to the genus Bacillus. A production method characterized by culturing a bacterial strain resistant to antibacterial substances produced by bacteria in a nutrient medium, producing this in the culture, and collecting L-lysine produced and accumulated from the culture. This invention relates to a method for producing lysine.

その目的は、医薬品あるいは飼料や食品への添加剤とし
て需要の大きいし一リジンを工業的安価に製造する方法
を提供することにある。
The purpose is to provide a method for industrially producing lysine, which is in great demand as an additive to pharmaceuticals, feeds, and foods, at low cost.

本発明におけるバチルス属細菌の生産する抗菌性物質と
はバチドラジン、チオシリン、リケニフォルミンス、バ
シリシン、コリスタチン、ポルシリン、セレキシン、グ
ラミシジン、チロシジン。
The antibacterial substances produced by bacteria belonging to the genus Bacillus in the present invention include batidrazine, thiocillin, licheniformin, basilicin, colistatin, porcillin, serexin, gramicidin, and tyrocidin.

チーフックチン。コリスチン、プレボリン、サーキュリ
ンもしくは抗菌性酵素を意味する。
Chee cook chin. Colistin, prevolin, circulin or antibacterial enzyme.

又抗菌性6ゲ素としてはサーモライシン、ズブチリシン
、ホスホリパーゼA、ホスホリパーゼC。
The six antibacterial substances include thermolysin, subtilisin, phospholipase A, and phospholipase C.

ホスホリパーゼD等が例示される。Examples include phospholipase D and the like.

従来、コリネバクテリウム、ブレビバクテリウム属の細
菌がL−リジンを生産すること、は知られている。また
、抗生物質耐性菌を用いる方法も知られている( U、
S、P3687810 )。
It has been known that bacteria of the genus Corynebacterium and Brevibacterium produce L-lysine. Additionally, methods using antibiotic-resistant bacteria are also known (U,
S, P3687810).

リジン生産における雑菌汚染は大きな問題で特に、連続
発酵においては汚染による収率低下の解決が要望されて
いる。その原因について検討の結果、多くは耐熱性胞子
を有するバチルス属の細菌の混入によってリジン生産菌
の生育が阻害されるためであることがわかった。この対
策としてバチルス属の生産する抗菌性物質に対して抵抗
性を有する変異株を用いることにより被害を大幅に軽減
できることを見い出した。
Bacterial contamination is a major problem in lysine production, and there is a need for a solution to the reduction in yield due to contamination, especially in continuous fermentation. As a result of examining the cause, it was found that the majority of the problems were due to the contamination of Bacillus bacteria with heat-resistant spores, which inhibited the growth of lysine-producing bacteria. As a countermeasure against this problem, we have found that the damage can be significantly reduced by using mutant strains that are resistant to antibacterial substances produced by Bacillus.

以下1本発明の詳細な説明する。The present invention will be explained in detail below.

本発明方法では、コリネバクテリウム属またはブレビバ
クテリウム属に属し、バチルス属細菌の生産する抗菌性
物質に対して抵抗性を有するし−リジン生産菌株であれ
ば、いかなる菌株をも用いることができる。
In the method of the present invention, any lysine-producing strain that belongs to the genus Corynebacterium or Brevibacterium and is resistant to antibacterial substances produced by bacteria of the genus Bacillus can be used. .

かかる変異株は、L−リジン生産線に前記性質を付与す
ることによって得ることもできるし、逆に前記性質を有
する菌にリジン生産性を付与することによって得られる
。本発明に用いる菌株は上記のごとき性質の他にL−リ
ジン生産に寄与するいかなる性質を備えていてもよい。
Such a mutant strain can be obtained by imparting the above properties to the L-lysine production line, or conversely, by imparting lysine productivity to a bacterium having the above properties. In addition to the above properties, the strain used in the present invention may have any properties that contribute to L-lysine production.

本発明に用いられる菌株の例が以下に示される。Examples of strains used in the present invention are shown below.

コリネバクテリウム・グルタミクム H−3330FE
RM P−6819H−3311FERM P−682
0 〃H−3386FERM P−6822ブレビバクテリ
ウム・ラクトファーメンタムH−3331FERM P
−6821 こ五らのうち、 H−3330,H−3371,H−3
386の菌株は、リジン生産能を有するコリネバクテリ
ウム・グルタミクム FERM−BP−158(チアリ
ジン、ストレフトマイシン、リファンピシン及び6−ア
ザウラシルに抵抗性〕の細胞を0.1規定トリス・マレ
イン酸緩衝液(pH6,0)中に10 日Ce1ls/
m+の濃度に懸濁し、ここにN−メチル−N′−ニトロ
−N−ニトロングアニジンを最終濃度0.2mg/ml
になるように添加し、室温で30分間静置した後。
Corynebacterium glutamicum H-3330FE
RM P-6819H-3311FERM P-682
0 H-3386FERM P-6822 Brevibacterium lactofermentum H-3331FERM P
-6821 Among the five, H-3330, H-3371, H-3
The 386 strain was prepared by culturing Corynebacterium glutamicum FERM-BP-158 (resistant to thialidin, streftomycin, rifampicin, and 6-azauracil) cells capable of producing lysine in 0.1N Tris-maleate buffer ( pH 6,0) for 10 days Ce1ls/
N-methyl-N'-nitro-N-nitronguanidine was suspended at a final concentration of 0.2 mg/ml.
After adding it so that it becomes like this and leaving it for 30 minutes at room temperature.

バチドラジン(BCT)5μg/mlまたは、グラミシ
ジン(GRM)50μg/mlを含む下記のごとき組成
を有する最少寒天平板培地と、サーモライシン(TL)
、500μg/mlを含む同様の寒天平板培地にそれぞ
れ塗布し、生育するコロニー必中から選択された変異株
であり、それぞれ、BCT、GRMあるいは、TL抵抗
性を有する点で。
A minimal agar plate medium having the following composition containing batidrazine (BCT) 5 μg/ml or gramicidin (GRM) 50 μg/ml, and thermolysin (TL)
, 500 μg/ml on a similar agar plate medium, and were selected from the colonies that grew, each having BCT, GRM, or TL resistance.

第1表に示すように親株と明らかに区別できる。As shown in Table 1, it can be clearly distinguished from the parent strain.

また、H−3331の菌株は、リジン生産能を有するブ
レビバクテリウム・ラクトファーメンタムFERM−P
6209  (チアリジン、ストレプトマイシン、リフ
ァンピシンに抵抗性、ロイシン要に区別できる。
In addition, the strain H-3331 is Brevibacterium lactofermentum FERM-P, which has lysine-producing ability.
6209 (resistant to thialidine, streptomycin, and rifampicin, can be distinguished by leucine).

第   1   表 上記最少寒天平板培地の組成ニゲルコース10g/β、
塩化アンモニウム4 g / 1 、  K H2P 
OaIg/p、に2HPO43g/β、MgSO47H
200,4g/I2.FeSO47H200,01’g
/ j!、 MnSO4・4H200,01g/β、尿
素2 g/It、ビオチン50μg/C寒天20g/C
L−ロイシン200μg/m1(pH7,2) 本発明に使用する培地組成としては使用菌株の利用しう
る炭素源窒素源無機物その他の必要な栄養素を程良く含
有するものであれば合成培地、天然培地のいずれも使用
できる。すなわち炭素源としてはグルコース、フラクト
ース、ソルビトール。
Table 1 Composition of the above minimal agar plate medium Nigelcose 10g/β,
Ammonium chloride 4 g/1, K H2P
OaIg/p, 2HPO43g/β, MgSO47H
200.4g/I2. FeSO47H200,01'g
/ j! , MnSO4・4H200,01g/β, urea 2g/It, biotin 50μg/C agar 20g/C
L-Leucine 200μg/ml (pH 7,2) The medium composition used in the present invention may be a synthetic medium or a natural medium as long as it contains appropriate amounts of carbon, nitrogen, inorganic substances, and other necessary nutrients that can be utilized by the strain used. Either can be used. In other words, carbon sources include glucose, fructose, and sorbitol.

グリセロール、蔗糖、澱粉、澱粉加水分解物、糖蜜、果
汁などの各種炭水化物、酢酸、フマール酸。
Various carbohydrates such as glycerol, sucrose, starch, starch hydrolyzate, molasses, fruit juice, acetic acid, fumaric acid.

乳酸、コハク酸などの有機酸、さらにエタノール。Organic acids such as lactic acid and succinic acid, as well as ethanol.

メタノールなどのアルコール類も使用できる。窒素源と
しては、アンモニア、塩化アンモニウム。
Alcohols such as methanol can also be used. Nitrogen sources include ammonia and ammonium chloride.

硫酸アンモニウム、酢酸アンモニウム、リン酸アンモニ
ウム等の各種無機酸のアンモニウム塩、尿素、アミン酸
、その他含窒素化合物、ならびにペプトン、肉エキス、
酵母エキス、コーン・スチープ・リカー、カゼイン加水
分解物、大豆粕酸加水゛分解物、各種発酵菌体およびそ
の消化物などが使用できる。さらに無機物としては、リ
ン酸第−カリウム、リン酸第二カリウム・リン酸マグネ
シウム、硫酸マグネシウム、塩化ナトリウム、硫酸第一
鉄、硫酸マンガン、炭酸カルシウムなどが使用される。
Ammonium salts of various inorganic acids such as ammonium sulfate, ammonium acetate, ammonium phosphate, urea, amino acid, other nitrogen-containing compounds, peptone, meat extract,
Yeast extract, corn steep liquor, casein hydrolyzate, soybean meal acid hydrolyzate, various fermented microbial cells and digested products thereof, etc. can be used. Furthermore, as inorganic substances, potassium phosphate, dipotassium phosphate/magnesium phosphate, magnesium sulfate, sodium chloride, ferrous sulfate, manganese sulfate, calcium carbonate, etc. are used.

本発明に使用する微生物が生育のために特定の栄養素を
必要とする場合には、その栄養素を適当量培地中に存在
させなければならないが。
If the microorganisms used in the present invention require specific nutrients for growth, the nutrients must be present in appropriate amounts in the culture medium.

これらの物質は窒素源として例示した天然榔に含まれて
添加させる場合がある。また培地中に各種の添加物2例
えば各種抗生物質、α−アミノ酪酸。
These substances may be added as a nitrogen source by being included in the natural bamboo. In addition, various additives 2 such as various antibiotics and α-aminobutyric acid are added to the medium.

システィン、ロイシン、ロイシン発酵液あるいはアスパ
ラギン酸、グルタミン酸などを添加することによりL−
リジン生産量を増加させつる場合がある。培養は振盪培
養あるいは深部通気攪拌培養などの好気的条件下で行う
。培養温度は通常20〜40℃の範囲で、培地のpHは
3〜9の範囲で。
By adding cysteine, leucine, leucine fermentation liquid or aspartic acid, glutamic acid, etc., L-
May increase lysine production. Cultivation is performed under aerobic conditions such as shaking culture or deep aeration agitation culture. The culture temperature is usually in the range of 20 to 40°C, and the pH of the medium is in the range of 3 to 9.

好ましくは中性付近に保持することが望ましいが。It is preferable to maintain it near neutrality.

これ以外の条件下でも使用菌株が生育すれば実施できる
。培地のpH調節は炭酸カルシウム、酸あるいはアルカ
リ溶液、pH緩衝剤などによって行う。通常1〜6日間
で培養液中にL−リジンが生成蓄積する。
It can be carried out under other conditions if the strain used grows. The pH of the medium is adjusted using calcium carbonate, acid or alkaline solutions, pH buffers, and the like. Usually, L-lysine is produced and accumulated in the culture solution in 1 to 6 days.

培養終了後、培養液より菌体などの沈殿物を除去し、公
知のイオン交換処理法、濃縮法、吸着法。
After culturing, precipitates such as bacterial cells are removed from the culture solution using known ion exchange treatment methods, concentration methods, and adsorption methods.

塩析法などを併用することにより、培養液からL−リジ
ンを回収するこ゛とができる。
L-lysine can be recovered from the culture solution by using a salting-out method or the like.

本発明を実施することによる効果としては雑菌汚染が発
生した場合の被害を大幅に軽減できることは言うまでも
なく、従来、雑菌汚染を防ぐため過剰な殺菌を行ってい
たのを最小限にすることができ、蒸気、エネルギーの大
幅な節約も可能となる。
It goes without saying that the effect of implementing the present invention is that damage in the event of bacterial contamination can be significantly reduced, and that conventional excessive sterilization to prevent bacterial contamination can be minimized. , steam, and energy can also be significantly saved.

以下、実施例をあげて本発明を具体的に示す。Hereinafter, the present invention will be specifically illustrated by giving examples.

実施例 種菌としてコリネバクテリウム・グルタミクムH−33
30(BCTR)を用いる。
Corynebacterium glutamicum H-33 as an example inoculum
30 (BCTR) is used.

この菌株をグルコース40g/β、HR3g/l、KH
2’PO41,5g/j!、に2HPO40、!5 g
 /β、 Mg5o4・lH2O0,5g/β。
Glucose 40g/β, HR3g/l, KH
2'PO41.5g/j! , 2HPO40,! 5g
/β, Mg5o4·lH2O0,5g/β.

ビオチン50μg/Cペプトン20 g/L酵母エキス
5g/lからなる種培地(p)I7.2)20mlを含
む3(10ml容三角)“ヲースコに120℃、30分
間オートクレーブ殺菌後接種し、30℃24時間培養す
る。
Biotin 50 μg/C peptone 20 g/L Yeast extract 5 g/L seed medium (p)I7.2) Containing 20 ml of 3 (10 ml triangular) “Waco” was sterilized by autoclaving at 120°C for 30 minutes, then inoculated at 30°C. Incubate for 24 hours.

この培養液2mlを廃糖蜜90g/β (グルコース換
算)、大豆粕酸加水分解物10g/j!’(大豆粕重量
換算)、硫安20 g/It、尿素3g/ρ。
2ml of this culture solution was mixed with 90g/β of blackstrap molasses (in terms of glucose) and 10g/j of soybean meal acid hydrolyzate! (converted to soybean meal weight), ammonium sulfate 20 g/It, urea 3 g/ρ.

MgSO4・7 H’20 0.5 g / j2 、
 K 2 HP O4Q、 7 g / A 、 Ca
 CO3’  30 g / j!からなる発酵培地(
pH7,2)20n+]を含む300m1容三角フラス
コ (120℃、30分間オートクレーブ殺菌)に接種
し、30℃で3日間振盪培養する。培養液中にL−リジ
ン(塩酸塩として、以下同様)が41.5g/j!生成
蓄積する。対照としてFERM−BP−158を用いる
他は上記と同様に実施して41g/βのリジンを得る。
MgSO4・7 H'20 0.5 g/j2,
K2HP O4Q, 7 g/A, Ca
CO3' 30 g/j! A fermentation medium consisting of (
pH 7.2) 20n+] was inoculated into a 300 ml Erlenmeyer flask (sterilized by autoclaving at 120°C for 30 minutes) and cultured with shaking at 30°C for 3 days. 41.5g/j of L-lysine (as hydrochloride, hereinafter the same) in the culture solution! Generate and accumulate. The same procedure as above is carried out except that FERM-BP-158 is used as a control to obtain 41 g/β lysine.

一方、バチドラジン生産能を有するバチルス・ズブチリ
スATCC14593を上記種培地で同様に培養し、5
00倍希釈しその1mlを上記リジン生産菌の植菌時に
同時に植菌して同様に培養を行い、培養液中にL−リジ
ンが33g/Il蓄積し。
On the other hand, Bacillus subtilis ATCC 14593, which has the ability to produce batidrazine, was similarly cultured in the above seed medium.
00 times diluted, 1 ml of the same was inoculated at the same time as the above-mentioned lysine-producing bacteria and cultured in the same manner, and 33 g/Il of L-lysine was accumulated in the culture solution.

FERM−B  P158を培養すると13.5g/β
であった。
When FERM-B P158 is cultured, 13.5 g/β
Met.

培養終了後、H−3330の汚染された培養液1βを遠
心分離して得た上清液を硫酸でpH1〜5に調整した後
ダイヤイオン5K−IB(H+型。
After completion of the culture, the supernatant liquid obtained by centrifuging the culture solution 1β contaminated with H-3330 was adjusted to pH 1 to 5 with sulfuric acid, and then Diaion 5K-IB (H+ type) was obtained.

強酸性イオン交換樹脂の商品名、三菱化成社製)のカラ
ムクロマトに通塔してL−リジンを吸着させ、カラムを
水洗後、稀アンモニア水で溶出してL−リジンを含む両
分を集めて濃縮する。濃縮液を塩酸でpH2に調整した
後、エタノールを添加しながら冷却することによりL−
リジンを晶出させ、L〜リジン塩酸塩の結晶26.5 
gを得た。
L-lysine was adsorbed by passing it through a column chromatograph using a strongly acidic ion exchange resin (trade name, manufactured by Mitsubishi Kasei Corporation), and after washing the column with water, it was eluted with dilute aqueous ammonia and both fractions containing L-lysine were collected. and concentrate. After adjusting the concentrated solution to pH 2 with hydrochloric acid, L-
Crystallize lysine, L ~ Crystals of lysine hydrochloride 26.5
I got g.

実施例2゜ 第2表に示す菌株を実施例1に示した種培地にそれぞれ
接種し30℃で24時間培養し、この培養液2mlをグ
ルコース90g/C大豆粕酸加水分解物20g/7! 
(大豆粕重量換算)、硫安20g/j!、尿素3 g 
/ 7!、 M g S Oa ・7 H200,5g
/β、  K、H2P Oa  1 g/ I!、  
ビオチン50、ljg/l)、”jイアミン・HCn 
 200pg/ml−、F 6SO4・7H2010m
g/ll、 Mn5Oa ・4H2010■/12.C
aCO220g/itからなる発酵培地(pH7,2)
20mlを含む3’00m1容三角フラスコ (120
℃、20分オートクレーブ殺菌)に接種し、30°Cで
3日間振盪培養を行って第2表に示す結果を得る。実施
例1と同様に培養したグラミシジン生産能を有するバチ
ルス・プレビスATCC8185を、 生JI菌に対し
て1/l000の比率植菌した時の結果を第2表に示す
Example 2 The strains shown in Table 2 were each inoculated into the seed medium shown in Example 1, cultured at 30°C for 24 hours, and 2 ml of this culture solution was mixed with 90 g of glucose/20 g of soybean meal acid hydrolyzate/7!
(converted to soybean meal weight), ammonium sulfate 20g/j! , 3 g of urea
/ 7! , M g S Oa ・7 H200,5g
/β, K, H2P Oa 1 g/ I! ,
Biotin 50, ljg/l), “jIamine・HCn
200pg/ml-, F6SO4・7H2010m
g/ll, Mn5Oa ・4H2010■/12. C
Fermentation medium (pH 7.2) consisting of aCO220g/it
3'00 ml Erlenmeyer flask containing 20 ml (120
℃, autoclave sterilization for 20 minutes) and cultured with shaking at 30°C for 3 days to obtain the results shown in Table 2. Table 2 shows the results when Bacillus plevis ATCC 8185, which was cultured in the same manner as in Example 1 and has the ability to produce gramicidin, was inoculated at a ratio of 1/1000 to live JI bacteria.

第   2   表 実施例3゜ 第3表に示す菌株を用いる他は、実施例1と同様に培養
を行い、第3表に示す結果を得る。生産培地のオートク
レーブ殺菌を100 ’c 20分にして同様に培養し
たときの結果も第3表に併せ、て示す。
Table 2 Example 3 The culture was carried out in the same manner as in Example 1, except that the strains shown in Table 3 were used, and the results shown in Table 3 were obtained. Table 3 also shows the results when the production medium was autoclaved at 100'C for 20 minutes and cultured in the same manner.

第   3   表 実施例4゜ 種菌としてH,−3330および、FERMBP−15
8を用い、実施例1に示し九種培地100m1を含む2
1容パンフル付三角フラスコに接種し30℃で24時間
振盪培養する。この培養液100m1を、廃糖蜜100
g/A!(グルコース換算)コーン・ステイープ・リカ
ー10g/L 硫安20g/il!、に2 HPO4,
1g/j!、Mg5Oa ・7H200,Sg/l、F
e5Oa・7H205■/1からなる発酵培地(’pH
6,8) 600rlを含む2A’容ジャーファーメン
タ−で32℃、攪拌数90Orpm、通気t 1 !l
 / minで培養し。
Table 3 Example 4 H, -3330 and FERMBP-15 as inoculum
2 containing 100 ml of the nine types of culture medium shown in Example 1.
The mixture was inoculated into a 1-volume Erlenmeyer flask with a pamphlet and cultured with shaking at 30°C for 24 hours. Add 100ml of this culture solution to 100ml of blackstrap molasses.
g/A! (Glucose equivalent) Corn steep liquor 10g/L Ammonium sulfate 20g/il! , to 2 HPO4,
1g/j! , Mg5Oa ・7H200, Sg/l, F
Fermentation medium consisting of e5Oa・7H205■/1 ('pH
6, 8) In a 2 A' jar fermenter containing 600 rl, at 32°C, stirring number 90 rpm, ventilation t 1! l
/min.

培養中゛pHを除菌したアンモニア水で6.8に制御す
る。初発の糖を消費した後は9次の組成のフィード液(
廃糖蜜200g/7!<グルコース換算〉。
During cultivation, the pH was controlled to 6.8 with sterilized ammonia water. After consuming the initial sugar, the feed liquid with the following composition (
Blackstrap molasses 200g/7! <Glucose conversion>.

硫安30g/β、KH2PO40,5g/Cl2O℃2
0分殺菌)を30 ml/ hrの速度で加える。発酵
槽の中の液量が1200m1を超えた時点から連続的に
30 ml/ hrの速度で無菌的に抜きとり、槽内の
液量を一定にする。いずれの菌株を用いても培養開始後
、50時間目からし一リジンの蓄積量が80 g/7!
に達する。無菌度を維持できればL−リジン蓄積量80
g/n以上を360時間以上持続が可能である。
Ammonium sulfate 30g/β, KH2PO40.5g/Cl2O℃2
sterilization) at a rate of 30 ml/hr. When the liquid volume in the fermenter exceeds 1200 ml, the liquid is continuously drained aseptically at a rate of 30 ml/hr to keep the liquid volume in the tank constant. No matter which strain was used, the amount of mustard-lysine accumulated 50 hours after the start of culture was 80 g/7!
reach. If sterility can be maintained, the amount of L-lysine accumulated is 80
g/n or higher for more than 360 hours.

しかし、フィード液の殺菌条件を100℃20分にした
場合、FERM  BP−158株は、80時間目です
でに10g/1.以下のリジン蓄積量になるが、、H−
3330株では150時間目まで70g/βを維持でき
る。
However, when the feed solution was sterilized at 100°C for 20 minutes, the FERM BP-158 strain was already 10 g/1. The amount of lysine accumulated is as follows, H-
For strain 3330, 70 g/β can be maintained until the 150th hour.

一方、フィード液の殺菌条件を120℃20分として、
培養100時間目に、実施例1と同様に培養したバチル
ス・ズブチリスATCC14593を0.L+++1添
加した場合、FERM  BP、158株は、120時
間目で70g/j!以下になるが。
On the other hand, the feed liquid was sterilized at 120°C for 20 minutes.
At 100 hours of culture, Bacillus subtilis ATCC14593 cultured in the same manner as in Example 1 was incubated at 0. When L+++1 was added, FERM BP, 158 strain was 70 g/j at 120 hours! It will be as follows.

H−3330株は190時間まで70g/β以上を維持
することができる。
H-3330 strain can maintain 70 g/β or more for up to 190 hours.

特許出願人(102)協和醗酵工業株式会社代表者 木
下祝部
Patent applicant (102) Kyowa Hakko Kogyo Co., Ltd. Representative Ikube Kinoshita

Claims (1)

【特許請求の範囲】 fi+  コリネバクテリウムまたはブレビバクテリウ
ムに属し、バチルス属細菌の生産する抗菌性物質に耐性
を有するし一リジン生産菌を栄養培地に培養し、培養液
中にL−リジンを生成せしめ。 培養液からし一リジンを採取することを特徴とするし一
リジンの製法 (2)  該抗菌性物質がv!累である特許請求の範囲
第1項記載の製法 (3)該抗菌酵素がサーモライシン、ズブチリシン。 ホスホリパーゼA、ホスホリパーゼC又はホスホリパー
ゼD′?′ある特許請求の範囲第2項記載の製法
[Claims] fi+ A lysine-producing bacterium belonging to Corynebacterium or Brevibacterium and resistant to antibacterial substances produced by Bacillus bacteria is cultured in a nutrient medium, and L-lysine is added to the culture medium. Generate. Method for producing perilla-lysine characterized by collecting perilla-lysine from a culture solution (2) The antibacterial substance is v! (3) The antibacterial enzyme is thermolysin or subtilisin. Phospholipase A, phospholipase C or phospholipase D'? 'Production method according to claim 2
JP58043742A 1983-03-16 1983-03-16 Production of l-lysine Granted JPS59169497A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP58043742A JPS59169497A (en) 1983-03-16 1983-03-16 Production of l-lysine

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP58043742A JPS59169497A (en) 1983-03-16 1983-03-16 Production of l-lysine

Publications (2)

Publication Number Publication Date
JPS59169497A true JPS59169497A (en) 1984-09-25
JPH0458316B2 JPH0458316B2 (en) 1992-09-17

Family

ID=12672216

Family Applications (1)

Application Number Title Priority Date Filing Date
JP58043742A Granted JPS59169497A (en) 1983-03-16 1983-03-16 Production of l-lysine

Country Status (1)

Country Link
JP (1) JPS59169497A (en)

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5544597B1 (en) * 1969-06-09 1980-11-13

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IN153057B (en) * 1978-09-21 1984-05-26 British Petroleum Co

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5544597B1 (en) * 1969-06-09 1980-11-13

Also Published As

Publication number Publication date
JPH0458316B2 (en) 1992-09-17

Similar Documents

Publication Publication Date Title
JP3698758B2 (en) Method for producing L-leucine by fermentation
JPS6236676B2 (en)
KR100198039B1 (en) Process for producing l-glutamic acid by fermentation
JP3016883B2 (en) Method for producing 5&#39;-xanthylic acid by fermentation method
JP3008565B2 (en) Method for producing L-glutamic acid by fermentation method
JPS6115695A (en) Preparation of l-isoleucine by fermentation method
JPS6257315B2 (en)
JP2876739B2 (en) Production method of L-lysine by fermentation method
JP3131311B2 (en) Production method of L-isoleucine by fermentation method
JPH0362395B2 (en)
JPH10248588A (en) Production of l-serine by fermentation
JPS6224074B2 (en)
JPH02131589A (en) Production of l-threonine by fermentation method
US3282794A (en) Method of producing citrulline by bacterial fermentation
JPH02283290A (en) Production of l-ornithine by fermentation method
JPH057493A (en) Production of l-valine by fermentation
JP2578474B2 (en) Method for producing L-glutamic acid
JPH01199589A (en) Production of l-lysine by fermentation method
JPS59169497A (en) Production of l-lysine
KR910008636B1 (en) Process for producing l - arginine
CA1192157A (en) Fermentative preparation of l-leucine
JP3006907B2 (en) Method for producing L-alanine by fermentation method
JPH029384A (en) Production of l-glutamic acid by fermentation process
US5118619A (en) Method for the fermentative production of L-isoleucine from D,L-α-hydroxybutyrate
JPS5988094A (en) Production of l-lysine by fermentation